|
|
| Research article summary (published 13 Aug 2006): |
A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers.
Full Abstract
OBJECTIVE:
Ibuprofen arginate is a salt formulation of ibuprofen designed to reach target concentrations rapidly. The primary objective of this study was to compare the 12-h pharmacokinetic profile of S(+)-ibuprofen following administration of single doses of ibuprofen arginate (600 mg) and dexibuprofen (400 mg) in healthy volunteers.
METHODS:
Twenty-four volunteers were recruited into an open-label, randomised, two-period, single-centre study with crossover design.
RESULTS:
Both treatments were well tolerated. Ibuprofen arginate and dexibuprofen showed similar bioavailability for S(+)-ibuprofen. Compared with dexibuprofen, ibuprofen arginate demonstrated a 45% higher maximum concentration (C(max)), and a time to peak concentration (T(max)) 2 h sooner.
CONCLUSION:
Ibuprofen arginate approaches maximum concentrations of S(+)-ibuprofen faster and higher than dexibuprofen.
Learn Faster Today Improve your study skills
Author information
Author/s: Sádaba, Belén (B); Campanero, Miguel A (MA); Muñoz-Juarez, Maria Jose (MJ); Gil-Aldea, Isabel (I); García-Quetglas, Emilio (E); Esteras, Antonio (A); Azanza, Jose R (JR);
Affiliation: Clinical Research Unit, Clínica Universitaria de Navarra, Universidad de Navarra, 31008, Pamplona, Spain. bsadaba(-atsign-)unav.es
Journal and publication information
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal: European journal of clinical pharmacology (Eur J Clin Pharmacol), published in Germany. (Language: eng)
Reference: 2006-Oct; vol 62 (issue 10) : pp 849-54
Dates: Created 2006/10/05; Completed 2007/12/12;
PMID: 16909273, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
30 Dec 1996 - Absence of an interaction between ibuprofen and zaleplon.
13 Jun 2000 - Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.
29 Sep 2001 - Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
29 Nov 2004 - An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies.
29 Sep 2005 - Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
30 Mar 1999 - Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis.
30 Mar 2002 - Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
28 Feb 2004 - Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.
30 Dec 2007 - Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects.
30 Dec 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.